Inventor
STUDLEY JOHN
GB44 patents
⚠️ This page may combine multiple inventors who share the name “STUDLEY JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
34 patentsUS7767672B2Aug 3, 2010
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA51 citations98
US9340546B2May 17, 2016
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA57 citations97
US9862709B2Jan 9, 2018
Processes for making compounds useful as inhibitors of ATR kinase
VERTEX PHARMA16 citations92
US9650381B2May 16, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations92
US9035053B2May 19, 2015
Processes for making compounds useful as inhibitors of ATR kinase
VERTEX PHARMA21 citations92
US8383633B2Feb 26, 2013
Aminopyrimidines useful as kinase inhibitors
VERTEX PHARMA26 citations92
US10787452B2Sep 29, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA5 citations84
US10392391B2Aug 27, 2019
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA4 citations84
US9670215B2Jun 6, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA11 citations84
US8957078B2Feb 17, 2015
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA19 citations84
US8853217B2Oct 7, 2014
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA16 citations84
US8765751B2Jul 1, 2014
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA16 citations84
US7652153B2Jan 26, 2010
Caspase inhibitors and uses thereof
VERTEX PHARMA13 citations84
US7351702B2Apr 1, 2008
Caspase inhibitors and uses thereof
VERTEX PHARMA10 citations84
US11465985B2Oct 11, 2022
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations83
US8846686B2Sep 30, 2014
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA16 citations82
US7553852B2Jun 30, 2009
Caspase inhibitors and uses thereof
VERTEX PHARMA9 citations82
US7335792B2Feb 26, 2008
Process for synthesizing aspartic and glutamic acid derivatives especially useful as intermediates in the manufacture of a caspase inhibitor
VERTEX PHARMA9 citations82
US11370798B2Jun 28, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA1 citations73
US11117900B2Sep 14, 2021
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10800781B2Oct 13, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA2 citations73
US10093676B2Oct 9, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations73
US11434201B2Sep 6, 2022
Processes for preparing pyrrolidine compounds
VERTEX PHARMA6 citations72
US10822331B2Nov 3, 2020
Processes for preparing ATR inhibitors
VERTEX PHARMA2 citations72
US10208027B2Feb 19, 2019
Processes for preparing ATR inhibitors
VERTEX PHARMA3 citations72
US10815239B2Oct 27, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US10160760B2Dec 25, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US12187731B2Jan 7, 2025
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations62
US12415798B2Sep 16, 2025
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA0 citations60
US11485739B2Nov 1, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations60
US9193722B2Nov 24, 2015
Tri-cyclic pyrazolopyridine kinase inhibitors
VERTEX PHARMA0 citations52
US7879891B2Feb 1, 2011
Caspase inhibitor prodrugs
VERTEX PHARMA0 citations52
US7875712B2Jan 25, 2011
Caspase inhibitors and uses thereof
VERTEX PHARMA0 citations52
US7442790B2Oct 28, 2008
Caspase inhibitors and uses thereof
VERTEX PHARMA0 citations52